Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review

Frederic Denis 1 , 2 , 3 , * , Jean-Francois Pelletier 4 , Jean-Christophe Chauvet-Gelinier 5 , Nathalie Rude 3 and Benoit Trojak 5
Authors Information
1 Department of Odontology, University Hospital of Dijon, 21079 Dijon, France
2 La Chartreuse Psychiatric Center, 21033 Dijon, France
3 EA 481 Neuroscience, IFR 133, University of Franche-Comte, 25030 Besancon, France
4 Department of Psychiatry, Montreal University, Yale Program for Recovery and Community Health, Canada
5 Department of Psychiatry and Addict logy, University Hospital of Dijon, 21079 Dijon, France
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: March 2018, 12 (1); e8062
  • Published Online: January 21, 2018
  • Article Type: Review Article
  • Received: August 1, 2016
  • Revised: November 10, 2016
  • Accepted: August 28, 2017
  • DOI: 10.5812/ijpbs.8062

To Cite: Denis F, Pelletier J, Chauvet-Gelinier J, Rude N, Trojak B. Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review, Iran J Psychiatry Behav Sci. 2018 ; 12(1):e8062. doi: 10.5812/ijpbs.8062.

Copyright © 2018, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
5. Conclusions
  • 1. Hafner H, an der Heiden W. Epidemiology of schizophrenia. Can J Psychiatry. 1997;42(2):139-51. doi: 10.1177/070674379704200204. [PubMed: 9067063].
  • 2. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 2000;250(6):274-85. [PubMed: 11153962].
  • 3. Ling Y, Watanabe M, Yoshii H, Akazawa K. Characteristics linked to the reduction of stigma towards schizophrenia: a pre-and-post study of parents of adolescents attending an educational program. BMC Public Health. 2014;14:258. doi: 10.1186/1471-2458-14-258. [PubMed: 24642069].
  • 4. Grisso T, Appelbaum PS. Comparison of standards for assessing patients' capacities to make treatment decisions. Am J Psychiatry. 1995;152(7):1033-7. doi: 10.1176/ajp.152.7.1033. [PubMed: 7793439].
  • 5. Tosh G, Clifton A, Bachner M. General physical health advice for people with serious mental illness. Schizophr Bull. 2011;37(4):671-3. doi: 10.1093/schbul/sbr005. [PubMed: 21471437].
  • 6. De Hert M, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health. 2006;2:14. doi: 10.1186/1745-0179-2-14. [PubMed: 16803620].
  • 7. Wildgust HJ, Hodgson R, Beary M. The paradox of premature mortality in schizophrenia: new research questions. J Psychopharmacol. 2010;24(4 Suppl):9-15. doi: 10.1177/1359786810382149. [PubMed: 20923916].
  • 8. Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188:122-7. doi: 10.1192/bjp.188.2.122. [PubMed: 16449697].
  • 9. Kisely S, Baghaie H, Lalloo R, Johnson NW. Association between poor oral health and eating disorders: systematic review and meta-analysis. Br J Psychiatry. 2015;207(4):299-305. doi: 10.1192/bjp.bp.114.156323. [PubMed: 26429686].
  • 10. Moore S, Shiers D, Daly B, Mitchell AJ, Gaughran F. Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand. 2015;132(2):109-21. doi: 10.1111/acps.12431. [PubMed: 25958971].
  • 11. Yaltirik M, Kocaelli H, Yargic I. Schizophrenia and dental management: review of the literature. Quintessence Int. 2004;35(4):317-20. [PubMed: 15119719].
  • 12. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The cochrane collaborations tool for assessing risk of bias in randomised trials. BMJ. 2011;343:5928. doi: 10.1136/bmj.d5928. [PubMed: 22008217].
  • 13. Bennett C, Khangura S, Brehaut JC, Graham ID, Moher D, Potter BK, et al. Reporting guidelines for survey research: an analysis of published guidance and reporting practices. PLoS Med. 2010;8(8):1001069. doi: 10.1371/journal.pmed.1001069. [PubMed: 21829330].
  • 14. Jenuwine ES, Floyd JA. Comparison of Medical Subject Headings and text-word searches in MEDLINE to retrieve studies on sleep in healthy individuals. J Med Libr Assoc. 2004;92(3):349-53. [PubMed: 15243641].
  • 15. Thomas A, Lavrentzou E, Karouzos C, Kontis C. Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dentist. 1996;16(2):84-6. [PubMed: 9084341].
  • 16. Velasco E, Machuca G, Martinez Sahuquillo A, Rios V, Lacalle J, Bullon P. Dental health among institutionalized psychiatric patients in Spain. Spec Care Dentist. 1997;17(6):203-6. [PubMed: 9791299].
  • 17. Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41(4):560-70. doi: 10.1097/01.MLR.0000053440.18761.F0. [PubMed: 12665719].
  • 18. McCreadie RG, Stevens H, Henderson J, Hall D, McCaul R, Filik R, et al. The dental health of people with schizophrenia. Acta Psychiatr Scand. 2004;110(4):306-10. doi: 10.1111/j.1600-0447.2004.00373.x. [PubMed: 15352933].
  • 19. Persson K, Axtelius B, Soderfeldt B, Ostman M. Monitoring oral health and dental attendance in an outpatient psychiatric population. J Psychiatr Ment Health Nurs. 2009;16(3):263-71. doi: 10.1111/j.1365-2850.2008.01364.x. [PubMed: 19291155].
  • 20. Chu KY, Yang NP, Chou P, Chiu HJ, Chi LY. Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study. BMC Public Health. 2010;10:482. doi: 10.1186/1471-2458-10-482. [PubMed: 20707911].
  • 21. Chu KY, Yang NP, Chou P, Chi LY, Chiu HJ. The relationship between body mass index, the use of second-generation antipsychotics, and dental caries among hospitalized patients with schizophrenia. Int J Psychiatry Med. 2011;41(4):343-53. doi: 10.2190/PM.41.4.d. [PubMed: 22238839].
  • 22. Chu KY, Yang NP, Chou P, Chiu HJ, Chi LY. Comparison of oral health between inpatients with schizophrenia and disabled people or the general population. J Formos Med Assoc. 2012;111(4):214-9. doi: 10.1016/j.jfma.2011.02.005. [PubMed: 22526210].
  • 23. Chu KY, Yang NP, Chou P, Chi LY, Chiu HJ. Dental prosthetic treatment needs of inpatients with schizophrenia in Taiwan: a cross-sectional study. BMC Oral Health. 2013;13:8. doi: 10.1186/1472-6831-13-8. [PubMed: 23331491].
  • 24. Zusman SP, Ponizovsky AM, Dekel D, Masarwa AE, Ramon T, Natapov L, et al. An assessment of the dental health of chronic institutionalized patients with psychiatric disease in Israel. Spec Care Dentist. 2010;30(1):18-22. doi: 10.1111/j.1754-4505.2009.00118.x. [PubMed: 20051070].
  • 25. Persson K, Olin E, Ostman M. Oral health problems and support as experienced by people with severe mental illness living in community-based subsidised housing--a qualitative study. Health Soc Care Community. 2010;18(5):529-36. doi: 10.1111/j.1365-2524.2010.00931.x. [PubMed: 20561079].
  • 26. Gurbuz O, Alatas G, Kurt E, Issever H, Dogan F. Oral health and treatment needs of institutionalized chronic psychiatric patients in Istanbul, Turkey. Community Dent Health. 2010;27(3):151-7. [PubMed: 21046906].
  • 27. Arnaiz A, Zumarraga M, Diez-Altuna I, Uriarte JJ, Moro J, Perez-Ansorena MA. Oral health and the symptoms of schizophrenia. Psychiatry Res. 2011;188(1):24-8. doi: 10.1016/j.psychres.2010.09.012. [PubMed: 21055830].
  • 28. Janardhanan T, Cohen CI, Kim S, Rizvi BF. Dental care and associated factors among older adults with schizophrenia. J Am Dent Assoc. 2011;142(1):57-65. [PubMed: 21193768].
  • 29. Nielsen J, Munk-Jorgensen P, Skadhede S, Correll CU. Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study. J Clin Psychiatry. 2011;72(2):140-3. doi: 10.4088/JCP.09m05318yel. [PubMed: 20584518].
  • 30. Tani H, Uchida H, Suzuki T, Shibuya Y, Shimanuki H, Watanabe K, et al. Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey. BMC Oral Health. 2012;12:32. doi: 10.1186/1472-6831-12-32. [PubMed: 22901247].
  • 31. Eltas A, Kartalci S, Eltas SD, Dundar S, Uslu MO. An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication. Int J Dent Hyg. 2013;11(2):78-83. doi: 10.1111/j.1601-5037.2012.00558.x. [PubMed: 22583707].
  • 32. Nikfarjam M, Parvin N. Oral health status in three long term care units of schizophrenic patients in chaharmahal-bakhtiari province, iran. Iran Red Crescent Med J. 2013;15(4):371-2. doi: 10.5812/ircmj.1892. [PubMed: 24083016].
  • 33. Bertaud-Gounot V, Kovess-Masfety V, Perrus C, Trohel G, Richard F. Oral health status and treatment needs among psychiatric inpatients in Rennes, France: a cross-sectional study. BMC Psychiatry. 2013;13:227. doi: 10.1186/1471-244X-13-227. [PubMed: 24053587].
  • 34. Shetty S, Bose A. Schizophrenia and periodontal disease: An oro-neural connection? A cross-sectional epidemiological study. J Indian Soc Periodontol. 2014;18(1):69-73. doi: 10.4103/0972-124X.128222. [PubMed: 24744548].
  • 35. Tang LR, Zheng W, Zhu H, Ma X, Chiu HF, Correll CU, et al. Self reported and interviewer rated oral health in patients with schizophrenia, bipolar disorder, and major depressive disorder. Perspect Psychiatr Care. 2016;52(1):4-11. doi: 10.1111/ppc.12096. [PubMed: 25515779].
  • 36. Grinshpoon A, Zusman SP, Weizman A, Ponizovsky AM. Dental Health and the Type of Antipsychotic Treatment in Inpatients with Schizophrenia. Isr J Psychiatry Relat Sci. 2015;52(2):114-8. [PubMed: 26431415].
  • 37. Wey MC, Loh S, Doss JG, Abu Bakar AK, Kisely S. The oral health of people with chronic schizophrenia: A neglected public health burden. Aust N Z J Psychiatry. 2016;50(7):685-94. doi: 10.1177/0004867415615947. [PubMed: 26560842].
  • 38. World health Organization . Oral health survey, basic methods. 5th ed. Geneva, Switzreland: World health Organization; 2013.
  • 39. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J. 1982;32(3):281-91. [PubMed: 6958657].
  • 40. Giddings G. Sense and sensitivity. CMAJ. 2013;185(18):1555. doi: 10.1503/cmaj.131617. [PubMed: 24324196].
  • 41. Autie A, Montreuil M, Moulier V, Braha S, Wojakiewicz A, Januel D. [Pain and schizophrenia: myth and reality]. Encephale. 2009;35(4):297-303. doi: 10.1016/j.encep.2008.04.005. [PubMed: 19748365].
  • 42. Malmo RB, Shagass C, Smith AA. Responsiveness in chronic schizophrenia. J Pers. 1951;19(4):359-75. [PubMed: 14874176].
  • 43. Singh MK, Giles LL, Nasrallah HA. Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract. 2006;12(2):90-102. [PubMed: 16728905].
  • 44. Raghunath A. Gingival pain, an unusual side effect of ziprasidone. BMJ Case Rep. 2013;2013. doi: 10.1136/bcr-2012-007577. [PubMed: 23283612].
  • 45. de Araujo AN, do Nascimento MA, de Sena EP, Baptista AF. Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper. Drug Healthc Patient Saf. 2014;6:21-7. doi: 10.2147/DHPS.S57172. [PubMed: 24648768].
  • 46. Szoke A, Trandafir A, Dupont ME, Meary A, Schurhoff F, Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry. 2008;192(4):248-57. doi: 10.1192/bjp.bp.106.029009. [PubMed: 18378982].
  • 47. Sartorius N. Stigma and mental health. Lancet. 2007;370(9590):810-1. doi: 10.1016/S0140-6736(07)61245-8. [PubMed: 17804064].
  • 48. Dworkin RH. Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull. 1994;20(2):235-48. [PubMed: 8085127].
  • 49. Kisely S, Smith M, Lawrence D, Cox M, Campbell LA, Maaten S. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ. 2007;176(6):779-84. doi: 10.1503/cmaj.060482. [PubMed: 17353530].
  • 50. Malone A, Conway DI. Payment methods may influence behaviour of primary care dentists. Evid Based Dent. 2015;16(1):4-5. doi: 10.1038/sj.ebd.6401071. [PubMed: 25909927].
  • 51. Nalliah RP, Da Silva JD, Allareddy V. The characteristics of hospital emergency department visits made by people with mental health conditions who had dental problems. J Am Dent Assoc. 2013;144(6):617-24. [PubMed: 23729459].
  • 52. De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138-51. [PubMed: 21633691].
  • 53. Barry MJ. Shared decision making: informing and involving patients to do the right thing in health care. J Ambul Care Manage. 2012;35(2):90-8. doi: 10.1097/JAC.0b013e318249482f. [PubMed: 22415282].
  • 54. Karazivan P, Dumez V, Flora L, Pomey MP, Del Grande C, Ghadiri DP, et al. The patient-as-partner approach in health care: a conceptual framework for a necessary transition. Acad Med. 2015;90(4):437-41. doi: 10.1097/ACM.0000000000000603. [PubMed: 25607943].
  • 55. Pelletier JF, Corbiere M, Lecomte T, Briand C, Corrigan P, Davidson L, et al. Citizenship and recovery: two intertwined concepts for civic-recovery. BMC Psychiatry. 2015;15:37. doi: 10.1186/s12888-015-0420-2. [PubMed: 25885779].
  • 56. Pelletier JF, Gifuny A, Nicole L, Labrie Racine G, Bordeleau J, Rowe M. Contributions of people using mental health services as partners in teaching psychiatry. Glob Health Promot. 2013;20(3):66-75. doi: 10.1177/1757975913499034. [PubMed: 23986385].
  • 57. Pelletier JF, D'Auteuil S, Ducasse C, Rodriguez Del Barrio L. [Public participation and civic participation of service users in relation to the Mental Health Action Plan 2005-2010: their spokesperson function]. Sante Ment Que. 2014;39(1):175-93. [PubMed: 25120121].
  • 58. Fratto G, Manzon L. Use of psychotropic drugs and associated dental diseases. Int J Psychiatry Med. 2014;48(3):185-97. doi: 10.2190/PM.48.3.d. [PubMed: 25492713].
  • 59. Romagna C, Dufour L, Troisgros O, Lorgis L, Richard C, Buffet P, et al. Periodontal disease: a new factor associated with the presence of multiple complex coronary lesions. J Clin Periodontol. 2012;39(1):38-44. doi: 10.1111/j.1600-051X.2011.01802.x. [PubMed: 22092604].
  • 60. Gurbuz O, Alatas G, Kurt E, Dogan F, Issever H. Periodontal health and treatment needs among hospitalized chronic psychiatric patients in Istanbul, Turkey. Community Dent Health. 2011;28(1):69-74. [PubMed: 21485239].
  • 61. Zelkha SA, Freilich RW, Amar S. Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol 2000. 2010;54(1):207-21. doi: 10.1111/j.1600-0757.2010.00358.x. [PubMed: 20712641].
  • 62. Brennan MT, Sankar V, Baccaglini L, Pillemer SR, Kingman A, Nunez O, et al. Oral manifestations in patients with aplastic anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(5):503-8. doi: 10.1067/moe.2001.116506. [PubMed: 11709685].
  • 63. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008;23 Suppl 1:27-41. doi: 10.1002/hup.917. [PubMed: 18098216].
  • 64. Muller N, Wagner JK, Krause D, Weidinger E, Wildenauer A, Obermeier M, et al. Impaired monocyte activation in schizophrenia. Psychiatry Res. 2012;198(3):341-6. doi: 10.1016/j.psychres.2011.12.049. [PubMed: 22429483].
  • 65. Yovel G, Sirota P, Mazeh D, Shakhar G, Rosenne E, Ben-Eliyahu S. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun. 2000;14(3):153-69. doi: 10.1006/brbi.1999.0574. [PubMed: 10970677].
  • 66. Maharaj B, Vayej AC. Awareness and knowledge of prophylaxis for infective endocarditis in patients with severe rheumatic heart disease. SADJ. 2013;68(2):68. 70-1. [PubMed: 23951767].
  • 67. Moazzam AA, Rajagopal SM, Sedghizadeh PP, Zada G, Habibian M. Intracranial bacterial infections of oral origin. J Clin Neurosci. 2015;22(5):800-6. doi: 10.1016/j.jocn.2014.11.015. [PubMed: 25800939].
  • 68. Druss BG, Bornemann TH. Improving health and health care for persons with serious mental illness: the window for US federal policy change. JAMA. 2010;303(19):1972-3. doi: 10.1001/jama.2010.615. [PubMed: 20483975].
  • 69. Nielsen J, Skadhede S, Correll CU. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients. Neuropsychopharmacology. 2010;35(9):1997-2004. doi: 10.1038/npp.2010.78. [PubMed: 20520598].
  • 70. Citrome L, Yeomans D. Do guidelines for severe mental illness promote physical health and well-being? J Psychopharmacol. 2005;19(6 Suppl):102-9. doi: 10.1177/0269881105059505. [PubMed: 16280343].
  • 71. Jones HF, Adams CE, Clifton A, Simpson J, Tosh G, Liddle PF, et al. An oral health intervention for people with serious mental illness (Three Shires Early Intervention Dental Trial): study protocol for a randomised controlled trial. Trials. 2013;14:158. doi: 10.1186/1745-6215-14-158. [PubMed: 23714397].
  • 72. Almomani F, Brown C, Williams KB. The effect of an oral health promotion program for people with psychiatric disabilities. Psychiatr Rehabil J. 2006;29(4):274-81. [PubMed: 16689038].
  • 73. Park S, Matthews N, Gibson C. Imitation, simulation, and schizophrenia. Schizophr Bull. 2008;34(4):698-707. doi: 10.1093/schbul/sbn048. [PubMed: 18499703].
  • 74. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud. 2007;44(3):457-66. doi: 10.1016/j.ijnurstu.2006.07.013. [PubMed: 17007859].
  • 75. BSDH Working Group . Oral health care for people with mental health problems guidelines and recommendations BSDH2000. The University of Adelaide: BSDH Guidelines,The National Oral Health Promotion Clearinghouse; 2000.
  • 76. Khokhar WA, Clifton A, Jones H, Tosh G. Oral health advice for people with serious mental illness. Cochrane Database Syst Rev. 2011;(11):8802. doi: 10.1002/14651858.CD008802.pub2. [PubMed: 22071856].
  • 77. Institut De Recherche Et Ducumentation En Economie De La Sante . Levolution des dispositifs de soins psychiatriques en Allemagne, Angleterre, France et Italie, similitudes et divergences qes180. France: IRDES; 2012, [cited 28 Avril]. Available from:
  • 78. Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25(4):284-90. [PubMed: 9332805].
  • 79. Grover S, Shah R, Kulhara P, Malhotra R. Internal consistency & validity of Indian disability evaluation and assessment scale (IDEAS) in patients with schizophrenia. Indian J Med Res. 2014;140(5):637-43. [PubMed: 25579145].
  • 80. de Chazeron I, Pereira B, Chereau-Boudet I, Brousse G, Misdrahi D, Fenelon G, et al. Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease. Schizophr Res. 2015;161(2-3):269-76. doi: 10.1016/j.schres.2014.11.010. [PubMed: 25481345].
  • 81. Lancon C, Reine G, Simeoni MC, Aghababian V, Auquier P. [Development and validation of a self rating quality of life scale: the S-QoL]. Encephale. 2007;33(3 Pt 1):277-84. [PubMed: 17675924].
  • 82. Atchison KA, Dolan TA. Development of the Geriatric Oral Health Assessment Index. J Dent Educ. 1990;54(11):680-7. [PubMed: 2229624].
  • 83. Abegg C, Fontanive VN, Tsakos G, Davoglio RS, de Oliveira MM. Adapting and testing the oral impacts on daily performances among adults and elderly in Brazil. Gerodontology. 2015;32(1):46-52. doi: 10.1111/ger.12051. [PubMed: 23581523].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments